Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2009
09/10/2009US20090226452 Method for enhancing or inhibiting insulin-like growth factor-i
09/10/2009US20090226451 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor
09/10/2009US20090226450 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor
09/10/2009US20090226449 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor
09/10/2009US20090226448 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor
09/10/2009US20090226447 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
09/10/2009US20090226444 Pharmaceutical antibody compositions with resistance to soluble cea
09/10/2009US20090226442 RON antibodies and uses thereof
09/10/2009US20090226441 Activin receptor-like kinase-1 compositions and methods of use
09/10/2009US20090226438 Polypeptides and Antibodies
09/10/2009US20090226435 Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
09/10/2009US20090226434 Afucosylated antibodies against CCR5 and their use for the treatment of inflammatory conditions
09/10/2009US20090226433 Compositions and methods for the therapy and diagnosis of influenza
09/10/2009US20090226430 Recombinant anti-cd4 antibodies for human therapy
09/10/2009US20090226428 Anti-inflammatory dab
09/10/2009US20090226426 Method for treating inflammation
09/10/2009US20090226423 Protein kinase C as a target for the treatment of respiratory syncytial virus
09/10/2009US20090226421 Recombinant monovalent antibodies and methods for production thereof
09/10/2009US20090226417 Human B7 polypeptides
09/10/2009US20090226416 Human G-Protein Chemokine Receptor (CCR5) HDGNR10
09/10/2009US20090226409 Pharmaceutical Compositions Comprising Sods and Prolamine Based Peptide Fragments
09/10/2009US20090226399 Medicaments comprising gene recombinant antibody against ganglioside gd3
09/09/2009EP2098865A1 Procedure for the detection of legionella spp using polyclonal antibodies
09/09/2009EP2098591A1 Hybridoma capable of producing anti-dectin-1 monoclonal antibody
09/09/2009EP2097747A1 Analytical method for analyzing c-terminus truncation
09/09/2009EP2097534A2 Human antibodies that bind cd70 and uses thereof
09/09/2009EP2097529A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof
09/09/2009EP2097526A2 Expression system of nell peptide
09/09/2009EP2097455A2 Humanized anti-factor d antibodies
09/09/2009EP2097454A2 4-1 bb ligand in inflammatory diseases
09/09/2009EP2097453A2 Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii)
09/09/2009EP2097452A1 Delivery of binding molecules to induce immunomodulation
09/09/2009EP2097451A2 Anti-chemokine (ccl2, ccl3, ccl5, cxcl11, cxcl12) single-domain antibodies
09/09/2009EP2097450A2 Antibody-based diagnostics and therapeutics
09/09/2009EP2097449A1 Peptides capable of binding to serum proteins
09/09/2009EP2097448A2 Method of detecting ocular diseases and pathologic conditions and treatment of same
09/09/2009EP2097447A2 Human monoclonal antibodies to btla and methods of use
09/09/2009EP2097446A2 Resistin antagonists and their use
09/09/2009EP2097105A2 Anti-p-selectin antibodies and methods of using the same to treat inflammatory diseases
09/09/2009EP2097104A2 New a-beta conformer selective anti-a-beta globulomer monoclonal antibodies
09/09/2009EP2097097A2 Human antibodies that bind cd22 and uses thereof
09/09/2009EP2097094A2 Biomarkers for neurological conditions
09/09/2009EP1809672B1 Atazanavir conjugates and antibibodies useful in immunossay
09/09/2009EP1761822A4 A dynamic fluid control system for immersion lithography
09/09/2009EP1651260B1 Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
09/09/2009EP1548028B1 Substituted type peptides of wt1
09/09/2009EP1379270B1 Use of anti-cd3 monoclonal antibodies and il-5 for treating autoimmune diseases
09/09/2009EP1098962B1 Diacylglycerol acyl transferase proteins
09/09/2009EP1015488B1 Interleukin-17 receptor-like protein
09/09/2009EP0996857B1 Cancer associated nucleic acids and polypeptides
09/09/2009EP0861261B1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
09/09/2009EP0817847B2 Il-17 receptor
09/09/2009EP0813545B1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
09/09/2009CN101528779A 4-1 BB ligand in inflammatory diseases
09/09/2009CN101528778A Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling
09/09/2009CN101528777A Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same
09/09/2009CN101528776A An ultra-high yield intravenous immune globulin preparation
09/09/2009CN101528775A Method for engineering immunoglobulins
09/09/2009CN101528774A Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
09/09/2009CN101525616A Preparation and application of sperm binding protein HEL-127 specifically expressed in human epididymis
09/09/2009CN101525615A Defensins gene expressed in human epididymis, and cloning, expression and application of same
09/09/2009CN101525385A Screening and preparation method and application for antibody medicament for malignant lymphoma and autoimmune diseases
09/09/2009CN101525384A A bispecific antibody and the making method and the application thereof
09/09/2009CN100537770C Von willebrand factor (vWF)-cleaving enzyme
09/09/2009CN100537601C Method of extracting pig immunoglobulin IgG in pig blood
09/09/2009CN100536919C Interferon antagon and usage of Flt3L antagon
09/08/2009US7585967 DNA or RNA having a modified backbone or base and a section that hybridizes to an EphrinB2 or EphB4 transcript causing gene expression inhibition; antineoplastic and antiproliferative agents can be synergistically administered with a second agent
09/08/2009US7585963 Useful for reducing chromosomal positional effects upon the transcription of a transgene operably linked to the ovalbumin transcriptional regulatory region and transfected into a recipient avian cell
09/08/2009US7585961 Nucleic acid encoding human antibodies specific for interleukin 15 (IL-15)
09/08/2009US7585954 Monoclonal antibody raised by immunizing a mammal with the polypeptide CSSEVGLLKNAEREQ; binds to protein expressed in keratinocytes
09/08/2009US7585953 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy
09/08/2009US7585952 Fully human miniantibody (scFv) called Erbicin, specific for the receptor ErbB2; antitumor; transmembrane tyrosine kinase receptor
09/08/2009US7585947 IL-7 drug substance, composition, preparation and uses
09/08/2009US7585946 Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions
09/08/2009US7585943 Peptide linker comprising thrombin cleavage site; enhancing recovery and purification of exogenously expressed polypeptides
09/08/2009US7585857 Cytotoxic agents comprising taxanes and their therapeutic use
09/08/2009US7585849 Position dependent recognition of GNN nucleotide triplets by zinc fingers
09/08/2009US7585835 GASP1: a follistatin domain containing protein
09/08/2009US7585673 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner
09/08/2009US7585671 Hedgehog interacting proteins and uses related thereto
09/08/2009US7585669 Genetic vaccine comprising an expression vector encoding a Streptococcus pneumoniae pneumolysin polypeptide that lacks hemolytic activity
09/08/2009US7585668 Humanized immunoglobulin loci
09/08/2009US7585659 Carotene synthase gene and uses therefor
09/08/2009US7585658 Staphylococcus aureus antigenic polypeptides and compositions
09/08/2009US7585637 Estrogen related receptor, ERRα, a regulator of bone formation
09/08/2009US7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptase
09/08/2009US7585619 Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity
09/08/2009US7585529 comprises ethanol aqueous solution in the presence of 2-mercaptoethanol and decoupling agent (urea), in phosphate buffer; for analysis of foods for celiac sufferers
09/08/2009US7585510 Use of the hypo3 gene, or homologue thereof, in the production of an Neisseria strain for the assessment, treatment or prevention of Neisseria infection; treatment of septicaemia and meningitis caused by Neisseria meningitidis
09/08/2009US7585507 Nucleic acid molecules and polypeptides for immune modulation
09/08/2009US7585506 Compositions and methods for the therapy and diagnosis of lung cancer
09/08/2009US7585505 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
09/08/2009US7585502 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunization
09/08/2009US7585501 Compositions and methods for treating kidney disease
09/08/2009US7585500 Fully human monoclonal antibodies to IL-13
09/08/2009CA2361887C Method of using anti-phospholipase a2 antibodies to enhance growth or improve feed efficiency
09/08/2009CA2294701C Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
09/08/2009CA2281955C Ikb kinase, subunits thereof, and methods of using same
09/03/2009WO2009108372A2 Antibodies as t cell receptor mimics, methods of production and uses thereof
09/03/2009WO2009107170A1 Anti-crp antibody and utilization of the same